KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ardelyx (ARDX) Research & Development (2016 - 2025)

Ardelyx (ARDX) has disclosed Research & Development for 12 consecutive years, with $22.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Research & Development rose 67.25% year-over-year to $22.9 million, compared with a TTM value of $71.5 million through Dec 2025, up 36.72%, and an annual FY2025 reading of $71.5 million, up 36.72% over the prior year.
  • Research & Development was $22.9 million for Q4 2025 at Ardelyx, up from $18.1 million in the prior quarter.
  • Across five years, Research & Development topped out at $26.0 million in Q2 2021 and bottomed at $7.5 million in Q3 2022.
  • Average Research & Development over 5 years is $14.3 million, with a median of $13.2 million recorded in 2024.
  • The sharpest move saw Research & Development soared 93.59% in 2021, then tumbled 68.49% in 2022.
  • Year by year, Research & Development stood at $21.0 million in 2021, then crashed by 56.4% to $9.1 million in 2022, then increased by 4.18% to $9.5 million in 2023, then surged by 43.49% to $13.7 million in 2024, then soared by 67.25% to $22.9 million in 2025.
  • Business Quant data shows Research & Development for ARDX at $22.9 million in Q4 2025, $18.1 million in Q3 2025, and $15.7 million in Q2 2025.